The UK's medicines regulator has approved the weight-loss drug Wegovy in pill form for the first time. Until now the treatment has been familiar mainly as an injection, and the decision opens the door to an oral version of the medicine.
The newly cleared product is a once-a-day tablet. For many people that is expected to be a more convenient option than having to inject themselves, something that could make the treatment easier to keep up with over time.
According to the announcement, it is the first tablet of its kind to be cleared by the Medicines and Healthcare Products Regulatory Agency, the body responsible for approving medicines in the UK. That makes the decision a notable step for weight-loss treatment in the country.
Wegovy is based on semaglutide, the same active ingredient already used in the injectable version of the drug, and is made by Novo Nordisk. The pill therefore offers a new way to take a medicine that has already become widely known.
The appeal of an oral form lies largely in accessibility. A daily tablet removes the need for needles, which can be a barrier for some patients, and may fit more easily into everyday routines than regular injections.
With the regulator's approval, the pill version now joins the injectable treatment as an authorised option in the UK. Its arrival reflects the growing role that weight-loss medicines have come to play in recent years.